Zoloft Birth Defects
Studies have found that the use of the antidepressant Zoloft during pregnancy can increase the risk of serious and potentially fatal birth defects. The Food and Drug Administration has issued a Zoloft warning concerning the risk of birth defects linked to the drug.
According to studies published by the New England Journal of Medicine, women who take Zoloft while pregnant are more likely to give birth to a child with heart defects such as persistent pulmonary hypertension of the newborn (PPHN), atrial septal defects (ASD), ventricular septal defects (VSD) and ventricular outflow tract obstruction defects.
The study found that Zoloft may also increase the risk of other heart defects, including coarctation of the aorta, hypoplastic left heart syndrome, transposition of the great arteries and tetralogy of Fallot. Other Zoloft birth defects that have been linked to the use of the antidepressant during pregnancy include craniosynostosis, omphalocele, cardiomyopathy and anencephaly.
Based on these findings on the link between Zoloft and birth defects, the FDA issued a warning to women who are being treated with Zoloft and who may become pregnant. Although the agency advised patients to consult with their doctor about whether it is safe to keep taking the antidepressant, the agency has not announced plans to issue a Zoloft recall.
If you or a loved one used Zoloft during pregnancy and gave birth to a child with heart defects or other congenital birth defects, you may qualify to file a lawsuit. For a free legal consultation, contact the lawyers at Hissey Kientz, LLP by calling us toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.